Surgery Partners

SGRY

Market cap $2.04B

BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”) in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The offering is expected to close on December 16, 2025, subject to certain customary closing conditions. The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees the Issuer's obligations under its senior secured credit facilities. The notes will be issued as part of the same series as the $800.0 million of 7.250% senior notes due 2032 originally issued in April 2024.

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”). The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities. The notes will be issued as part of the same series as the Issuer's 7.250% senior notes due 2032 originally issued in April 2024.

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

It missed on the top line and whiffed significantly on analyst estimates in its third quarter. The company did manage to grow its revenue by almost 7% year over year.

Surgery Partners, Inc. ( SGRY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants David Doherty - Executive VP & CFO J. Evans - CEO & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Andrew Mok - Barclays Bank PLC, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Ryan Langston - TD Cowen, Research Division Presentation Operator Greetings, and welcome to the Surgery Partners' Third Quarter 2025 Earnings Call.

Surgery Partners (SGRY) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.19 per share a year ago.

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, Ltd., has announced the acquisition of a minority ownership interest in Valley Ambulatory Surgery Center (Valley ASC) in partnership with Surgery Partners. This collaboration strengthens Duly's commitment to expanding access to high-quality, affordable outpatient surgical care across the Chicagoland area. Valley ASC, located in St. Charles, Illinois, is a respected, multispec.

Surgery Partners (SGRY -0.34%), a leading operator of ambulatory surgical facilities, announced its results for the second quarter on August 5, 2025. The company reported GAAP revenue of $826.2 million, surpassing analyst GAAP estimates of $818.4 million, while Non-GAAP earnings per share (EPS) came in at $0.17, slightly missing the $0.18 consensus (non-GAAP).

Surgery Partners, Inc. (NASDAQ:SGRY ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants David T. Doherty - Executive VP & CFO J.